Craif
Tokyo
About Craif
Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for many cancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $35.5M
- Funding stage: Late Stage Venture
- Last round: Debt Financing (Apr 2025)
- Website: craif.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Diagnostics, Machine Learning, Medical
Social Profiles
Canonical: https://fsome.com/organization/craif-94892 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.